Ritholtz Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41M Buy
44,966
+7,755
+21% +$895K 0.09% 142
2025
Q4
$3.92M Buy
37,211
+10,305
+38% +$967K 0.07% 195
2025
Q3
$2.26M Buy
26,906
+410
+2% +$33.8K 0.04% 299
2025
Q2
$2.1M Sell
26,496
-14,311
-35% -$1.14M 0.05% 284
2025
Q1
$3.66M Sell
40,807
-6,900
-14% -$644K 0.11% 130
2024
Q4
$4.75M Sell
47,707
-2,286
-5% -$236K 0.14% 90
2024
Q3
$5.68M Sell
49,993
-109
-0.2% -$12.9K 0.17% 71
2024
Q2
$6.2M Buy
50,102
+978
+2% +$126K 0.2% 62
2024
Q1
$6.48M Buy
49,124
+636
+1% +$78.4K 0.22% 56
2023
Q4
$5.29M Sell
48,488
-4,826
-9% -$501K 0.21% 57
2023
Q3
$5.49M Buy
53,314
+1,756
+3% +$189K 0.25% 52
2023
Q2
$5.95M Buy
51,558
+951
+2% +$108K 0.27% 49
2023
Q1
$5.38M Sell
50,607
-1,106
-2% -$119K 0.27% 50
2022
Q4
$5.74M Sell
51,713
-1,896
-4% -$194K 0.32% 49
2022
Q3
$4.62M Buy
53,609
+26,883
+101% +$2.4M 0.25% 53
2022
Q2
$2.44M Buy
26,726
+5,985
+29% +$531K 0.15% 76
2022
Q1
$1.7M Buy
20,741
+4,983
+32% +$393K 0.12% 108
2021
Q4
$1.21M Buy
15,758
+1,578
+11% +$126K 0.08% 135
2021
Q3
$1.06M Buy
14,180
+1,238
+10% +$94.2K 0.07% 132
2021
Q2
$1.01M Buy
12,942
+1,352
+12% +$101K 0.07% 141
2021
Q1
$853K Buy
11,590
+2,092
+22% +$154K 0.07% 131
2020
Q4
$741K Sell
9,498
-448
-5% -$34.3K 0.07% 115
2020
Q3
$787K Buy
9,946
+489
+5% +$38.3K 0.09% 97
2020
Q2
$698K Buy
9,457
+4,149
+78% +$312K 0.09% 87
2020
Q1
$390K Sell
5,308
-2,256
-30% -$177K 0.06% 89
2019
Q4
$656K Buy
7,564
+449
+6% +$36.9K 0.1% 70
2019
Q3
$571K Buy
7,115
+130
+2% +$10.4K 0.09% 71
2019
Q2
$559K Sell
6,985
-155
-2% -$11.9K 0.1% 70
2019
Q1
$567K Buy
7,140
+337
+5% +$25.2K 0.1% 70
2018
Q4
$496K Buy
6,803
+418
+7% +$29.5K 0.11% 67
2018
Q3
$432K Buy
6,385
+33
+0.5% +$2.1K 0.11% 69
2018
Q2
$368K Buy
6,352
+1,523
+32% +$85.9K 0.1% 77
2018
Q1
$251K Sell
4,829
-134
-3% -$7.24K 0.07% 99
2017
Q4
$266K Buy
+4,963
New +$275K 0.08% 95

Other funds holding MRK

Ritholtz Wealth Management's MRK Position: Q1 2026 in Review

Ritholtz Wealth Management increased its Merck (MRK) stake by 21% in Q1 2026, buying an estimated $895K and bringing the position to 44,966 shares worth $5.41M. The position accounts for 0.09% of the portfolio, ranked #142.

Ritholtz Wealth Management first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.48M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ritholtz Wealth Management held 44,966 shares of Merck worth $5.41M as of Q1 2026.
  • Ritholtz Wealth Management bought 7,755 Merck shares in Q1 2026, an estimated $895K.
  • Merck made up 0.09% of Ritholtz Wealth Management's portfolio in Q1 2026, its #142 holding.
  • Ritholtz Wealth Management first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • Ritholtz Wealth Management's Merck position peaked at $6.48M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.